ACAT-1 gene rs1044925 SNP and its relation with different clinical forms of chronic Chagas disease
暂无分享,去创建一个
C. Padovani | R. D. dos Santos | P. C. Pereira | C. Kurokawa | Thaysa Buss Carvalho | A. Latini | Luiz Roberto de Oliveira Júnior
[1] H. Garelick,et al. Evolution of Chagas’ disease in Brazil. Epidemiological perspective and challenges for the future: a critical review , 2017, Perspectives in public health.
[2] M. O. Rocha,et al. Pathogenicity of Chagas Disease Cardiopathy , 2017 .
[3] E. Amsterdam,et al. The Epidemiology, Clinical Manifestations, and Management of Chagas Heart Disease , 2015, Clinical cardiology.
[4] I. Marcipar,et al. Chagas disease, a risk factor for high blood pressure , 2014, Blood pressure.
[5] Fnu Nagajyothi,et al. High Fat Diet Modulates Trypanosoma cruzi Infection Associated Myocarditis , 2014, PLoS neglected tropical diseases.
[6] K. Gollob,et al. Acute Chagas Disease: New Global Challenges for an Old Neglected Disease , 2014, PLoS neglected tropical diseases.
[7] P. C. Pereira,et al. Challenges and perspectives of Chagas disease: a review , 2013, Journal of Venomous Animals and Toxins including Tropical Diseases.
[8] R. Gürtler,et al. Certifying the interruption of Chagas disease transmission by native vectors: cui bono? , 2013, Memorias do Instituto Oswaldo Cruz.
[9] Jinzhen Wu,et al. Interactions of Several Lipid-Related Gene Polymorphisms and Cigarette Smoking on Blood Pressure Levels , 2012, International journal of biological sciences.
[10] Jinzhen Wu,et al. Sex-specific association of ACAT-1 rs1044925 SNP and serum lipid levels in the hypercholesterolemic subjects , 2012, Lipids in Health and Disease.
[11] H. Moraes-Souza,et al. [Control of transfusional transmission]. , 2011, Revista da Sociedade Brasileira de Medicina Tropical.
[12] Jinzhen Wu,et al. Polymorphism of rs1044925 in the acyl-CoA:cholesterol acyltransferase-1 gene and serum lipid levels in the Guangxi Bai Ku Yao and Han populations , 2010, Lipids in Health and Disease.
[13] M. Guariento,et al. Chagas' disease and ageing: the coexistence of other chronic diseases with Chagas' disease in elderly patients. , 2009, Revista da Sociedade Brasileira de Medicina Tropical.
[14] J. Marin-Neto,et al. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. , 2009, Memorias do Instituto Oswaldo Cruz.
[15] K. Gollob,et al. Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease. , 2009, Memorias do Instituto Oswaldo Cruz.
[16] Elina Ikonen,et al. Cellular cholesterol trafficking and compartmentalization , 2008, Nature Reviews Molecular Cell Biology.
[17] R. Mortara,et al. Novel strategy in Trypanosoma cruzi cell invasion: implication of cholesterol and host cell microdomains. , 2007, International journal for parasitology.
[18] E. Almeida,et al. Freqüência da hipertensão arterial em chagásicos crônicos e sua repercussão no coração: estudo clínico e anatomopatológico , 2007 .
[19] P. C. Pereira,et al. Clinical and nutritional profile of individuals with Chagas disease. , 2007, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[20] C. Block,et al. Mechanisms linking obesity with cardiovascular disease , 2006, Nature.
[21] Jenefer M Blackwell,et al. Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? , 2006, The Lancet Infectious Diseases.
[22] S. Barreto,et al. Hipertensão arterial no Brasil: estimativa de prevalência a partir de estudos de base populacional , 2006 .
[23] Paul Poirier,et al. Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism , 2006, Circulation.
[24] Zhaoxia Yu,et al. Single Nucleotide Polymorphisms and Their Applications , 2006 .
[25] Catherine C. Y. Chang,et al. Human ACAT1 gene expression and its involvement in the development of atherosclerosis. , 2006, Future cardiology.
[26] Ministério da Saúde. Secretaria de Vigilância em Saúde,et al. [Brazilian Consensus on Chagas disease]. , 2005, Revista da Sociedade Brasileira de Medicina Tropical.
[27] T. Huizinga,et al. Interleukin-10 promoter single-nucleotide polymorphisms as markers for disease susceptibility and disease severity in leprosy , 2004, Genes and Immunity.
[28] B. Starfield,et al. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. , 2002, Archives of internal medicine.
[29] P. Bozza,et al. The cellular biology of eosinophil eicosanoid formation and function. , 2002, The Journal of allergy and clinical immunology.
[30] G. S. Shelness,et al. Cholesterol esters and atherosclerosis–a game of ACAT and mouse , 2000, Nature Medicine.
[31] M. Stear,et al. Molecular markers and their use in animal breeding. , 2000, Veterinary journal.
[32] J. Glaz,et al. Simultaneous confidence intervals for multinomial proportions , 1999 .
[33] V. D. P. Teixeira,et al. Freqüência de diabetes mellitus e hiperglicemia em mulheres chagásicas e não-chagásicas , 1999 .
[34] A. Dvorak,et al. Cytoplasmic lipid bodies in eosinophils: central roles in eicosanoid generation. , 1999, International archives of allergy and immunology.
[35] L. Brooks,et al. A DNA polymorphism discovery resource for research on human genetic variation. , 1998, Genome research.
[36] M. E. Guariento,et al. Interação clínica entre moléstia de Chagas e hipertensão arterial primária em um serviço de referência ambulatorial , 1998 .
[37] L V Kirchhoff,et al. American Trypanosomiasis (Chagas Disease) , 2018, Red Book (2018).
[38] D. Kwiatkowski,et al. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. , 1994, Nature.
[39] J Nyboe,et al. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. , 1988, Stroke.
[40] W. Kannel,et al. Atherosclerosis risk factors. , 1987, Pharmacology & therapeutics.
[41] R. Isturiz,et al. Chagas Disease , 2021, Neglected Tropical Diseases.
[42] L. A. Goodman. Simultaneous Confidence Intervals for Contrasts Among Multinomial Populations , 1964 .
[43] T. B. Morillo,et al. [Chagas' disease; American trypanosomiasis]. , 1955, La Medicina colonial.